Ototoksisitenin İzlenmesi
Özet
Referanslar
Lord SG. Monitoring Protocols for Cochlear Toxicity. Semin Hear. 2019;40(2):122-43.
Campbell KCM, Le Prell CG. Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Saf. 2018;41(5):451-64.
Ganesan P, Schmiedge J, Manchaiah V, Swapna S, Dhandayutham S, Kothandaraman PP. Ototoxicity: A Challenge in Diagnosis and Treatment. J Audiol Otol. 2018;22(2):59-68.
Ototoxicity Monitoring Programs: Addressing Existing Barriers [Internet]. 2023. Available from: https://www.audiologyonline.com/audiology-ceus/course/ototoxicity-monitoring-programs-addressing-existing-38807.
Fligor BJ. Pediatric Ototoxicity: Current Trends and Management. Semin Hear. 2019;40(2):154-61.
Gambacorta V, Orzan E, Faralli M, Gulla M, Lapenna R, Baietta I, et al. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center. Audiol Res. 2023;13(5):779-90.
Association AS-L-H. Audiologic management of individuals receiving cochleotoxic drug therapy. 1994.
Durrant J, Campbell K, Fausti S, Guthrie O, Jacobson G, Lonsbury-Martin B, Poling G. American Academy of Audiology position statement and clinical practice guidelines: ototoxicity monitoring. Wahington: American Academiy of Audiology. 2009.
King KA, Brewer CC. Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making. Int J Audiol. 2018;57(sup4):S89-s98.
Dille MF, McMillan GP, Helt WJ, Konrad-Martin D, Jacobs P. A Store-and-Forward Tele-Audiology Solution to Promote Efficient Screenings for Ototoxicity during Cisplatin Cancer Treatment. J Am Acad Audiol. 2015;26(9):750-60.
Referanslar
Lord SG. Monitoring Protocols for Cochlear Toxicity. Semin Hear. 2019;40(2):122-43.
Campbell KCM, Le Prell CG. Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Saf. 2018;41(5):451-64.
Ganesan P, Schmiedge J, Manchaiah V, Swapna S, Dhandayutham S, Kothandaraman PP. Ototoxicity: A Challenge in Diagnosis and Treatment. J Audiol Otol. 2018;22(2):59-68.
Ototoxicity Monitoring Programs: Addressing Existing Barriers [Internet]. 2023. Available from: https://www.audiologyonline.com/audiology-ceus/course/ototoxicity-monitoring-programs-addressing-existing-38807.
Fligor BJ. Pediatric Ototoxicity: Current Trends and Management. Semin Hear. 2019;40(2):154-61.
Gambacorta V, Orzan E, Faralli M, Gulla M, Lapenna R, Baietta I, et al. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center. Audiol Res. 2023;13(5):779-90.
Association AS-L-H. Audiologic management of individuals receiving cochleotoxic drug therapy. 1994.
Durrant J, Campbell K, Fausti S, Guthrie O, Jacobson G, Lonsbury-Martin B, Poling G. American Academy of Audiology position statement and clinical practice guidelines: ototoxicity monitoring. Wahington: American Academiy of Audiology. 2009.
King KA, Brewer CC. Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making. Int J Audiol. 2018;57(sup4):S89-s98.
Dille MF, McMillan GP, Helt WJ, Konrad-Martin D, Jacobs P. A Store-and-Forward Tele-Audiology Solution to Promote Efficient Screenings for Ototoxicity during Cisplatin Cancer Treatment. J Am Acad Audiol. 2015;26(9):750-60.
